2013
DOI: 10.3892/ol.2013.1666
|View full text |Cite
|
Sign up to set email alerts
|

Histone deacetylase inhibitor, valproic acid, radiosensitizes the C6 glioma cell line in vitro

Abstract: Valproic acid (VPA) is a well-tolerated drug that is used to treat seizure disorders and that has recently been shown to inhibit histone deacetylase. The present study investigated the effects of VPA on the radiosensitization of the rat C6 glioma cell line in vitro. To select an appropriate treatment concentration and time, MTT and flow cytometry assays were performed to measure the inhibitory effects of VPA at various concentrations and incubation time-points. The radiosensitizing effect of VPA was determined… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
19
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 22 publications
(20 citation statements)
references
References 43 publications
1
19
0
Order By: Relevance
“…Their radio-protective effects have also previously been associated with reduced apoptosis (26). On the other hand VA has a radio-sensitizing effect on cancer cells through apoptosis induction (27). Our data on the radio-protective effect of VA are consistent with previous studies.…”
Section: Discussionsupporting
confidence: 83%
“…Their radio-protective effects have also previously been associated with reduced apoptosis (26). On the other hand VA has a radio-sensitizing effect on cancer cells through apoptosis induction (27). Our data on the radio-protective effect of VA are consistent with previous studies.…”
Section: Discussionsupporting
confidence: 83%
“…Thereby, reintroduction of p21 expression, together with inhibition of cyclin D1 could be regarded as a more universal mechanism of VPA action on cancer cells. Several studies demonstrated that VPA can decrease activity/expression of proteins necessary for cancer progression, including anti-apoptotic protein survivin in neuroblastoma cells [ 23 ] or Bcl-2 on the mRNA and protein levels of in C6 glioma cells [ 24 ]. VPA could down-regulate of SMAD4, which resulted in reduced prostate cancer cell invasiveness probably trough the inhibition of the epithelial-mesenchymal transition [ 25 ].…”
Section: Introductionmentioning
confidence: 99%
“…Through this HDAC inhibitor function, VPA has been shown to be cytotoxic and proapoptotic in cancer cells, particularly in regards to glioma [19][20][21]. It is also structurally similar to butyrate, a known apoptotic agent [22].…”
Section: Introductionmentioning
confidence: 99%